Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00118209. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma
ClinicalTrials.gov study NCT03189524. IPD Sharing: YES. Countries: 1. Publications: 3.
Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts
ClinicalTrials.gov study NCT03160079. IPD Sharing: NO. Countries: 1. Publications: 9.
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
ClinicalTrials.gov study NCT03448393. IPD Sharing: YES. Countries: 1. Publications: 4.
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
ClinicalTrials.gov study NCT00577278. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies
ClinicalTrials.gov study NCT02343120. IPD Sharing: Not stated. Countries: 6. Publications: 8.
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00381680. IPD Sharing: YES. Countries: 4. Publications: 1.
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
ClinicalTrials.gov study NCT05460533. IPD Sharing: YES. Countries: 1. Publications: 0.
CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion
ClinicalTrials.gov study NCT00579124. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B
ClinicalTrials.gov study NCT03277729. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL
ClinicalTrials.gov study NCT02055820. IPD Sharing: Not stated. Countries: 10. Publications: 3.
Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02926833. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
ClinicalTrials.gov study NCT01287741. IPD Sharing: Not stated. Countries: 29. Publications: 14.
Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
ClinicalTrials.gov study NCT00086580. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination
ClinicalTrials.gov study NCT02485639. IPD Sharing: NO. Countries: 1. Publications: 6.
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
ClinicalTrials.gov study NCT00057811. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
ClinicalTrials.gov study NCT04035434. IPD Sharing: NO. Countries: 6. Publications: 0.
A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
ClinicalTrials.gov study NCT02018861. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
ClinicalTrials.gov study NCT00924326. IPD Sharing: NO. Countries: 1. Publications: 10.
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT00869999. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.